If you are experiencing a medical emergency, contact emergency services immediately: Emergency contacts and medical assistance
Crisis Scenario 1 — Severe RA Flare
A severe flare is not the same as a bad pain day. A severe flare involves marked joint swelling, heat, loss of function, and systemic symptoms (fever, profound fatigue). It may require in-hospital IV corticosteroid therapy (methylprednisolone) and a rheumatologist-directed management change.
Warning signs requiring urgent medical attention: - Multiple joints suddenly hot, swollen, and extremely painful within 24–48 hours - High fever with joint symptoms (rule out septic arthritis — a joint infection — which is a separate medical emergency requiring different treatment) - Inability to use hands, wrists, or feet for basic daily functions - Chest pain or breathlessness (RA can affect the lungs and pericardium)
What to do: - Contact your rheumatologist urgently. Most have provision for urgent review. - If you cannot reach your rheumatologist and symptoms are severe, go to an emergency department. - A short course of oral prednisone (bridge therapy) is often initiated by your rheumatologist — if you've been given a flare management plan, follow it. - Septic arthritis is the differential you must rule out: If one joint is dramatically more swollen and hot than the others — especially in the context of fever — this could be a joint infection, not a flare. Septic arthritis requires emergency joint aspiration and IV antibiotics.
Crisis Scenario 2 — Serious Infection on Biologic or JAK Inhibitor Therapy
Biologic DMARDs (adalimumab, etanercept, tocilizumab) and JAK inhibitors (tofacitinib, baricitinib) suppress the immune system. This increases infection risk — including serious infections that can deteriorate rapidly.
Warning signs while on biologic/JAK therapy: - High fever (> 38.5°C), rigors, or feeling profoundly unwell - Productive cough, breathlessness, chest pain (bacterial pneumonia, pulmonary TB reactivation) - Skin infection spreading rapidly (cellulitis) - Urinary symptoms with fever (complicated UTI / pyelonephritis)
What to do: 1. Stop your biologic or JAK inhibitor immediately if you develop a serious infection. Do not continue it until the infection is resolved and your rheumatologist has reviewed. 2. Seek emergency medical care. Infections on immune-suppressing therapy can progress faster than usual. 3. Tell every treating clinician that you are on a biologic or JAK inhibitor — this affects which organisms they screen for and how aggressively they treat. 4. If you have had TB in the past or are in a high-exposure setting, flag this urgently — TNF inhibitors can reactivate latent TB.
Crisis Scenario 3 — Joint Replacement: The Financial Emergency
A total knee or hip replacement is planned or has just happened. The financial question: what will this cost out-of-pocket?
Let's focus on what we can control.
| Situation | What Applies |
|---|---|
| CDL registered + in-network specialist | PMB covers the procedure. Scheme rate applied. Minimal OOP if specialist bills at scheme rate. |
| CDL registered + specialist bills above scheme rate | Gap cover (if held) pays the shortfall. This is the common scenario. Orthopaedic surgeons frequently bill above scheme rate. |
| CDL registered + scheme applies sub-limits | Some schemes cap joint replacement cover. Gap cover with sub-limit protection closes this. |
| No gap cover | OOP shortfall can be R15,000–R40,000 for surgeon + anaesthesiologist billing above rate. |
Before joint replacement surgery: 1. Ask your orthopaedic surgeon what they bill vs what the scheme pays. Get this in writing. 2. Ask your scheme for a cost estimate and confirm the PMB motivation has been submitted (the CDL supports this). 3. If you have gap cover, notify your gap insurer and confirm the procedure is covered. 4. If you don't have gap cover, negotiate a scheme-rate agreement with the surgeon upfront.
Gap Cover: What It Does and Doesn't Do for RA
| Scenario | Gap Cover Helps? |
|---|---|
| Methotrexate and csDMARD costs | NO — CDL covers this |
| Biologic OOP cost (not scheme-funded) | NO — gap cover does not cover formulary exclusions |
| Severe flare hospitalisation: specialist shortfall | YES — rheumatologist shortfall |
| Septic arthritis: orthopaedic surgeon shortfall | YES |
| Total knee or hip replacement: surgeon shortfall | YES — this is the primary gap cover use case for RA |
| Surgical sub-limits on joint replacement | YES (sub-limit cover products specifically) |
The bottom line: Gap cover matters most for RA patients at the joint replacement stage and for serious infections on biologic therapy. It does not help with biologic drug OOP cost — that is a scheme formulary problem, not a gap problem.
Check your RA cover before a flare or surgery. Run your AURA check